New Melanoma Drug Targets Genetic Mutation

The Food and Drug Administration has approved Zelboraf, a first-of-its-kind drug to treat melanoma by targeting a particular genetic mutation found in about half of patients, Dr. Cheryl Burgess, of the Center for Dermatology and Dermatological Surgery, explains.